LncRNA XIST modulates miR‐328‐3p ectopic expression in lung injury induced by tobacco‐specific lung carcinogen NNK both in vitro and in vivo

Bingxin Li,Xuezheng Li,Zhe Jiang,Di Zhou,Yuan Feng,Gang Chen,Ning Li

DOI: https://doi.org/10.1111/bph.16373

IF: 7.3

2024-04-10

British Journal of Pharmacology

Abstract:Background and Purpose It is well acknowledged that tobacco‐derived lung carcinogens can induce lung injury and even lung cancer through a complex mechanism. MicroRNAs (MiRNAs) are differentially expressed in tobacco‐derived carcinogen nicotine‐derived nitrosamine ketone (NNK)‐treated A/J mice. Experimental Approach RNA sequencing was used to detect the level of long non‐coding RNAs (lncRNAs). Murine and human lung normal and cancer cells were used to evaluate the function of lncRNA XIST and miR‐328‐3p in vitro, and NNK‐treated A/J mice were used to test their function in vivo. In vivo levels of miR‐328‐3p and lncRNA XIST were analysed, using in situ hybridization. miR‐328‐3p agomir and lncRNA XIST‐specific siRNA were used to manipulate in vivo levels of miR‐328‐3p and lncRNA XIST in A/J mice. Key Results LncRNA XIST was up‐regulated in NNK‐induced lung injury and dominated the NNK‐induced ectopic miRNA expression in NNK‐induced lung injury both in vitro and in vivo. Either lncRNA XIST silencing or miR‐328‐3p overexpression exerted opposing effects in lung normal and cancer cells regarding cell migration. LncRNA XIST down‐regulated miR‐328‐3p levels as a miRNA sponge, and miR‐328‐3p targeted the 3′‐UTR of FZD7 mRNA, which is ectopically overexpressed in lung cancer patients. Both in vivo lncRNA XIST silencing and miR‐328 overexpression could rescue NNK‐induced lung injury and aberrant overexpression of the lung cancer biomarker CK19 in NNK‐treated A/J mice. Conclusions and Implications Our results highlight the promotive effect of lncRNA XIST in NNK‐induced lung injury and elucidate its post‐transcriptional mechanisms, indicating that targeting lncRNA XIST/miR‐328‐3p could be a potential therapeutic strategy to prevent tobacco carcinogen‐induced lung injury in vivo.

pharmacology & pharmacy